These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 12556649

  • 1. The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.
    Phillips RA, Kloner RA, Grimm RH, Weinberger M.
    J Clin Hypertens (Greenwich); 2003; 5(1):17-23. PubMed ID: 12556649
    [Abstract] [Full Text] [Related]

  • 2. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF, Duprez D, Purkayastha D, Samuel R, Ferdinand KC.
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.
    Vasc Health Risk Manag; 2011 Aug; 7():701-8. PubMed ID: 22174580
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J.
    Clin Ther; 1996 Aug; 18(4):608-25. PubMed ID: 8879890
    [Abstract] [Full Text] [Related]

  • 5. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
    Volpe M, Junren Z, Maxwell T, Rodriguez A, Gamboa R, Gomez-Fernandez P, Ortega-Gonzalez G, Matadamas N, Rodriguez F, Dass B, Kyle C, Clarysse L, Bryce A, Moreno-Heredia E, Germano G, Gilles L, Smith RD, Sanderson JE, CDSP-944 Study Group.
    Clin Ther; 2003 May; 25(5):1469-89. PubMed ID: 12867222
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY, Ahn T, Bae JH, Lim DS, Lee SU, Kim YK, Hyon MS, Kim WH, Han KR, Park HK.
    Clin Ther; 2014 Oct 01; 36(10):1402-11. PubMed ID: 25146365
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):189-95. PubMed ID: 22462558
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    Clin Ther; 1996 Jun 01; 18(3):411-28. PubMed ID: 8829017
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM, Youn JC, Chae SC, Park CG, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Shin DG, Jeong JW, Yoon JH, Park SH, Kwon J, Cho SY.
    Clin Ther; 2011 Dec 01; 33(12):1953-63. PubMed ID: 22136978
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M, Hosoai H, Ikewaki K, Ayaori M, Yamashita T, Shige H, Higashi K, Nashida Y, Shimizu S, Kijima F, Yokoyama M, Nakamura H, ABC Study Group.
    Clin Ther; 2013 Apr 01; 35(4):461-73. PubMed ID: 23490288
    [Abstract] [Full Text] [Related]

  • 14. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
    Conlin PR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    J Hum Hypertens; 1998 Oct 01; 12(10):693-9. PubMed ID: 9819017
    [Abstract] [Full Text] [Related]

  • 15. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Virolainen J, Kontula K.
    Am J Hypertens; 2007 Mar 01; 20(3):311-8. PubMed ID: 17324745
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S, Aurup P, Snavely D, Goldberg A.
    Am J Cardiol; 2001 Mar 15; 87(6):721-6. PubMed ID: 11249890
    [Abstract] [Full Text] [Related]

  • 17. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 15; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 18. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.
    Hypertension; 2009 Jul 15; 54(1):32-9. PubMed ID: 19470877
    [Abstract] [Full Text] [Related]

  • 19. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M, Crikelair N, Yen J, Glazer R.
    Vasc Health Risk Manag; 2010 Sep 07; 6():821-7. PubMed ID: 20859551
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
    Payeras AC, Sladek K, Lembo G, Alberici M.
    Clin Drug Investig; 2007 Sep 07; 27(9):623-32. PubMed ID: 17705571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.